Milica Pesic (Milica Pešić)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Diagnostics (Basel, Switzerland)

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Jelena Dinic, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pesic
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers 16 (11) (2024)
Jelena Dinic, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pesic
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors. Cancers 16 (11) (2024)
Milka Jadranin, Danica Savić, Ema Lupšić, Ana Podolski-Renić, Milica Pesic, Vele Tešević, Slobodan Milosavljević, Gordana Krstić
LC-ESI QToF MS Non-Targeted Screening of Latex Extracts of Euphorbia seguieriana ssp. seguieriana Necker and Euphorbia cyparissias and Determination of Their Potential Anticancer Activity. Plants (Basel, Switzerland) 12 (24) (2023)
Sofija Jovanović Stojanov, Epole N Ntungwe, Jelena Dinic, Ana Podolski-Renić, Milica Pajović, Patrícia Ríjo, Milica Pesic
Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition. Pharmaceutics 15 (7) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Jelena Dinic, Ana Podolski-Renić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Mirna Jovanović, Dušica Petrović Rodić, Dragana Marić, Maja Ercegovac, Milica Pesic
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Milka Jadranin, Danica Savić, Ema Lupšić, Ana Podolski-Renić, Milica Pesic, Vele Tešević, Slobodan Milosavljević, Gordana Krstić
LC-ESI QToF MS Non-Targeted Screening of Latex Extracts of Euphorbia seguieriana ssp. seguieriana Necker and Euphorbia cyparissias and Determination of Their Potential Anticancer Activity. Plants (Basel, Switzerland) 12 (24) (2023)
Epole N Ntungwe, Sofija Jovanović Stojanov, Noélia M Duarte, Nuno R Candeias, Ana M Díaz-Lanza, Máté Vágvölgyi, Attila Hunyadi, Milica Pesic, Patrícia Ríjo
C 20 - nor -Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators. ACS medicinal chemistry letters 13 (4) (2022)
Mirna Jovanović, Tijana Stanković, Sonja Stojković Burić, Jasna Banković, Jelena Dinic, Mila Ljujić, Milica Pesic, Miodrag Dragoj
Decreased TSPAN14 Expression Contributes to NSCLC Progression. Life (Basel, Switzerland) 12 (9) (2022)
Berta Segura-Collar, Juan Jiménez-Sanchez, Ricardo Gargini, Miodrag Dragoj, Juan Manuel Sepúlveda Sánchez, Milica Pesic, María A Ramírez, Luis E Ayala-Hernández, Vicente A Torres, Victor M Pérez-García
On optimal temozolomide scheduling for slowly growing glioblastomas. Neuro-oncology advances 4 (1) (2022)
Sofija Jovanović Stojanov, Ana Stepanović, Mila Ljujić, Ema Lupšić, Silvia Schenone, Milica Pesic, Jelena Dinic
Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4- d ]pyrimidine Tyrosine Kinase Inhibitors. Life (Basel, Switzerland) 12 (10) (2022)
Ana Podolski-Renić, Jelena Dinic, Tijana Stanković, Ivanka Tsakovska, Ilza Pajeva, Tiziano Tuccinardi, Lorenzo Botta, Silvia Schenone, Milica Pesic
New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors. Cancers 13 (21) (2021)
Ana Kostić, Sofija Jovanović Stojanov, Ana Podolski-Renić, Marija Stepanović, Miodrag Dragoj, Igor Nikolić, Goran Tasić, Silvia Schenone, Milica Pesic, Jelena Dinic
Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells. Brain sciences 11 (7) (2021)
Miodrag Dragoj, Jasmina Stojkovska, Tijana Stanković, Jelena Dinic, Ana Podolski-Renić, Bojana Obradović, Milica Pesic
Development and Validation of a Long-Term 3D Glioblastoma Cell Culture in Alginate Microfibers as a Novel Bio-Mimicking Model System for Preclinical Drug Testing. Brain sciences 11 (8) (2021)
Iris Neto, Eva María Domínguez-Martín, Epole Ngolle Ntungwe, Catarina Pinto Reis, Milica Pesic, Célia M C Faustino, Patrícia Ríjo
Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment. Pharmaceutics 13 (6) (2021)
Petar Stupar, Ana Podolski-Renić, Maria Ines Villalba, Miodrag Dragoj, Sofija Jovanović Stojanov, Milica Pesic, Sandor Kasas
Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics. Medicina (Kaunas, Lithuania) 57 (5) (2021)
Ahmed Dhahir Latif, Tamás Jernei, Ana Podolski-Renić, Ching-Ying Kuo, Máté Vágvölgyi, Gábor Girst, István Zupkó, Sedef Develi, Engin Ulukaya, Hui-Chun Wang, Milica Pesic, Antal Csámpai, Attila Hunyadi
Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling. Antioxidants (Basel, Switzerland) 9 (6) (2020)
Marija Stepanović, Aleksandra Divac Rankov, Ana Podolski-Renić, Igor Nikolić, Goran Tasić, Arianna Mancini, Silvia Schenone, Milica Pesic, Jelena Dinic
Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo. Cancers 12 (6) (2020)
Patrícia Ríjo, Milica Pesic, Ana Fátima Carvalho Fernandes, Claudia Nunes Dos Santos
Natural Products: Optimizing Cancer Treatment through Modulation of Redox Balance. Oxidative medicine and cellular longevity 2020 (2020)
Arturo Álvarez-Arenas, Ana Podolski-Renic, Juan Belmonte-Beitia, Milica Pesic, Gabriel F Calvo
Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer. Scientific reports 9 (1) (2019)
Jelena Dinic, Ana Podolski-Renić, Mirna Jovanović, Loana Musso, Ivanka Tsakovska, Ilza Pajeva, Sabrina Dallavalle, Milica Pesic
Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. International journal of molecular sciences 20 (18) (2019)
Sonja Stojković Burić, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, Mirna Jovanović, Stefan Hadžić, Jose M Ayuso, María Virumbrales-Muñoz, Luis Jose Fernández, Ignacio Ochoa, Victor M Pérez-García, Milica Pesic
Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo. Oxidative medicine and cellular longevity 2019 (2019)
Catarina Garcia, Epole Ngolle Ntungwe, Ana Rebelo, Cláudia Bessa, Tijana Stankovic, Jelena Dinic, Ana María Díaz-Lanza, Catarina Pinto Reis, Amílcar Roberto, Paula Pereira, Maria-João Cebola, Lucília Saraiva, Milica Pesic, Noélia Duarte, Patrícia Ríjo
Parvifloron D from Plectranthus strigosus: Cytotoxicity Screening of Plectranthus spp. Extracts. Biomolecules 9 (10) (2019)
Laura Fási, Florent Di Meo, Ching-Ying Kuo, Sonja Stojkovic Buric, Ana Martins, Norbert Kúsz, Zoltán Béni, Miklós Dékány, György Tibor Balogh, Milica Pesic, Hui-Chun Wang, Patrick Trouillas, Attila Hunyadi
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging. Journal of medicinal chemistry 62 (3) (2019)
Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, Marija Stepanović, Arianna Mancini, Enrico Rango, Giulia Iovenitti, Alessio Molinari, Francesca Bugli, Maurizio Sanguinetti, Riccardo Torelli, Maurizio Martini, Laura Maccari, Massimo Valoti, Elena Dreassi, Maurizio Botta, Milica Pesic, Silvia Schenone
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. Cancers 11 (6) (2019)
Zorica Milošević, Jasna Banković, Jelena Dinić, Chrisiida Tsimplouli, Evangelia Sereti, Miodrag Dragoj, Verica Paunović, Zorka Milovanović, Marija Stepanović, Nikola Tanić, Kostantinos Dimas, Milica Pesic
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma. Cellular oncology (Dordrecht) 41 (4) (2018)